These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 4323443

  • 41. Virologic and immunologic aspects of feline picornaviruses.
    Bürki F.
    J Am Vet Med Assoc; 1971 Mar 15; 158(6):Suppl 2:916-9. PubMed ID: 4930307
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. New human adenovirus isolated from a renal transplant recipient: description and characterization of candiate adenovirus type 34.
    Hierholzer JC, Atuk NO, Gwaltney JM.
    J Clin Microbiol; 1975 Apr 15; 1(4):366-76. PubMed ID: 170313
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH, Buescher EL, Bancroft WH, Russell PK.
    J Infect Dis; 1971 Aug 15; 124(2):155-60. PubMed ID: 4330998
    [No Abstract] [Full Text] [Related]

  • 48. [Epidemic of respiratory tract diseases in newborn infants due to ECHO 11 virus].
    Hercík L, Huml M, Mimra J, Nájemník J, Procházka D, Venderová E.
    Zentralbl Bakteriol Orig; 1970 Aug 15; 213(1):18-27. PubMed ID: 5454245
    [No Abstract] [Full Text] [Related]

  • 49. Epidemic keratoconjunctivitis. A severe industrial outbreak due to adenovirus type 8.
    Sprague JB, Hierholzer JC, Currier RW, Hattwick MA, Smith MD.
    N Engl J Med; 1973 Dec 20; 289(25):1341-6. PubMed ID: 4356635
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
    Li Q, Liu Q, Huang W, Song A, Zhao C, Wu J, Wang Y.
    Hum Vaccin Immunother; 2017 Jun 03; 13(6):1-8. PubMed ID: 28301274
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Development of immunological response in children living in closed children communities to adenoviral nosocomial infection in their 1st years of life].
    Holý J, Vanĕcek K.
    Cesk Pediatr; 1972 Jul 03; 27(7):317-9. PubMed ID: 4340691
    [No Abstract] [Full Text] [Related]

  • 54. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.
    Edmondson WP, Purcell RH, Gundelfinger BF, Love JW, Ludwig W, Chanock RM.
    JAMA; 1966 Feb 07; 195(6):453-9. PubMed ID: 4285433
    [No Abstract] [Full Text] [Related]

  • 55. Comparative trials of RA 27-3 and Cendehill rubella vaccines in adult and adolescent females.
    Fogel A, Moshkowitz A, Rannon L, Gerichter CB.
    Am J Epidemiol; 1971 May 07; 93(5):392-8. PubMed ID: 5556399
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Problems in developing a respiratory vaccine.
    Chang TW.
    N Engl J Med; 1970 Dec 03; 283(23):1287. PubMed ID: 5476483
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.